CL2023001746A1 - Composición farmacéutica de agonistas duales de glp 1/glp 2 - Google Patents

Composición farmacéutica de agonistas duales de glp 1/glp 2

Info

Publication number
CL2023001746A1
CL2023001746A1 CL2023001746A CL2023001746A CL2023001746A1 CL 2023001746 A1 CL2023001746 A1 CL 2023001746A1 CL 2023001746 A CL2023001746 A CL 2023001746A CL 2023001746 A CL2023001746 A CL 2023001746A CL 2023001746 A1 CL2023001746 A1 CL 2023001746A1
Authority
CL
Chile
Prior art keywords
lpg
agonists
pharmaceutical composition
dual
relates
Prior art date
Application number
CL2023001746A
Other languages
English (en)
Inventor
Skodborg Villadsen Jesper
Giehm Lise
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Publication of CL2023001746A1 publication Critical patent/CL2023001746A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas que comprenden conservantes particulares.
CL2023001746A 2020-12-16 2023-06-14 Composición farmacéutica de agonistas duales de glp 1/glp 2 CL2023001746A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20214559 2020-12-16

Publications (1)

Publication Number Publication Date
CL2023001746A1 true CL2023001746A1 (es) 2024-01-19

Family

ID=73855071

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2023001746A CL2023001746A1 (es) 2020-12-16 2023-06-14 Composición farmacéutica de agonistas duales de glp 1/glp 2

Country Status (11)

Country Link
EP (1) EP4262747A1 (es)
JP (1) JP2023553562A (es)
KR (1) KR20230121822A (es)
CN (1) CN116669752A (es)
AU (1) AU2021399904A1 (es)
CA (1) CA3200525A1 (es)
CL (1) CL2023001746A1 (es)
IL (1) IL301892A (es)
MX (1) MX2023006281A (es)
TW (1) TW202241492A (es)
WO (1) WO2022129305A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3228429A1 (en) * 2021-09-03 2023-03-09 Mikkel Askjar Agersnap Dosage regime
WO2024061919A1 (en) * 2022-09-19 2024-03-28 Zealand Pharma A/S Combination therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT929567E (pt) 1996-09-09 2005-07-29 Zealand Pharma As Sintese em fase solida de peptidos
CN114939156A (zh) * 2014-01-09 2022-08-26 赛诺菲 门冬胰岛素的稳定化药物制剂
TW201833132A (zh) * 2016-12-02 2018-09-16 法商賽諾菲公司 作為肽類ｇｌｐ１／升糖素／ｇｉｐ三重受體激動劑之新穎化合物
KR102502040B1 (ko) 2016-12-09 2023-02-24 질랜드 파마 에이/에스 아실화 glp-1/glp-2 이중 효능제

Also Published As

Publication number Publication date
AU2021399904A1 (en) 2023-06-08
KR20230121822A (ko) 2023-08-21
CN116669752A (zh) 2023-08-29
EP4262747A1 (en) 2023-10-25
CA3200525A1 (en) 2022-06-23
JP2023553562A (ja) 2023-12-22
IL301892A (en) 2023-06-01
TW202241492A (zh) 2022-11-01
MX2023006281A (es) 2023-06-13
WO2022129305A1 (en) 2022-06-23

Similar Documents

Publication Publication Date Title
CL2023001746A1 (es) Composición farmacéutica de agonistas duales de glp 1/glp 2
BR112019006194A2 (pt) composições que compreendem um ligante de ligação ao receptor de canabinóides
BR112019024785A2 (pt) composto de bifenila ou sal do mesmo, composição farmacêutica, agente antineoplásico e uso
GT201300096A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1
BR112015030543A2 (pt) glicerol formador de película para aplicação tópica
BR112021024431A2 (pt) Inibidores da via de resposta ao estresse integrada
EA202192405A1 (ru) Составы антител против il-36r
BR112015023387A2 (pt) composições lipídicas de racecodotril
BR112022022587A2 (pt) Composição encapsulada compreendendo microcápsulas do tipo núcleo-invólucro e processo para a sua preparação
BRPI0922813B8 (pt) composição termofixa para partes e revestimentos compósitos intumescentes
BR112016026660A2 (pt) ?produto extemporâneo para cuidados cosméticos e/ou dermatológicos, e, kit de preparação extemporânea de uma composição cosmética e/ou dermatológica?
CL2023001745A1 (es) Composición farmacéutica de agonistas duales de glp-1/glp-2
CL2023001747A1 (es) Composición farmacéutica de agonistas duales de glp-1/glp-2
CL2021003273A1 (es) Composición farmacéutica parenteral del agonista dual glp1/2
BR112015022520A2 (pt) composições de ligante e métodos para produzir e usar as mesmas
CL2021002837A1 (es) Formas sólidas de un inhibidor de glyt1
BR112022004980A2 (pt) Composições de poliamida, método para fabricar um artigo e método para fazer uma composição de poliamida
AR106981A1 (es) Una composición antimicrobiana
BR112023003106A2 (pt) Forma amorfa de um inibidor de malt1 e formulações do mesmo
DOP2015000155A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
WO2021044231A3 (es) Compuestos de curcumina y aminoácidos básicos
BR112021022193A2 (pt) Composições tópicas
BR112022025158A2 (pt) Composição fluorescente compreendendo pelo menos um composto do tipo benzazol para a proteção de produtos
BR112023000117A2 (pt) Composição
BR112022014331A2 (pt) Composição de asfalto, processo para preparar uma composição de asfalto e uso da composição